Etravirine Pharmacokinetics In HIV-Infected Pregnant Women

Etravirine Pharmacokinetics In HIV-Infected Pregnant Women

Background: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women. Methods: IMPAACT P1026s and PANNA are on-going, nonrandomized, open-label, parallel-group, multi-center phase-IV prospective studies in HIV-infected pregnant women. Intensive...

Full description

Bibliographic Details
Main Authors: Nikki Mulligan, Stein Schalkwijk, Brookie M. Best, Angela Colbers, Jiajia Wang, Edmund V. Capparelli, José Moltó, Alice M. Stek, Graham Taylor, Elizabeth Smith, Carmen Hidalgo-Tenorio, Nahida Chakhtoura, Marjo van Kasteren, Courtney V. Fletcher, Mark Mirochnick, David Burger
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Pharmacology
Subjects:
HIV
Pregnancy
pharmacokinetics
etravirine
Perinatal transmission
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00239/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00239/full

Similar Items